Citation Impact
Citing Papers
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
2005 Standout
Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions
2009 StandoutScience
Trained immunity: A program of innate immune memory in health and disease
2016 StandoutScience
Marked Genomic Differences Characterize Primary and Secondary Glioblastoma Subtypes and Identify Two Distinct Molecular and Clinical Secondary Glioblastoma Entities
2006
Inositol phosphatase SHIP1 is a primary target of miR-155
2009 Nobel
Induction of interferon-stimulated gene expression and antiviral responses require protein deacetylase activity
2004 StandoutNobel
Hallmarks of Cancer: The Next Generation
2011 Standout
MiR-424 and miR-155 deregulated expression in cytogenetically normal acute myeloid leukaemia: correlation with NPM1 and FLT3 mutation status
2012
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
2008 StandoutNature
The promise and challenge of therapeutic genome editing
2020 StandoutNatureNobel
Retinoic acid receptors: From molecular mechanisms to cancer therapy
2014
Gemini: A Noninferiority Study of Saquinavir/Ritonavir Versus Lopinavir/Ritonavir as Initial HIV-1 Therapy in Adults
2009
Quantitative HOX expression in chromosomally defined subsets of acute myelogenous leukemia
2002
Epigenetics in human disease and prospects for epigenetic therapy
2004 StandoutNature
Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
2002 Standout
Impact of normalization on miRNA microarray expression profiling
2009
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
2011 StandoutNature
Targeting microRNAs in cancer: rationale, strategies and challenges
2010
Cytogenetics in acute leukemia
2003
Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials
2010
Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia
2001 Standout
Unravelling the complexity of metastasis — molecular understanding and targeted therapies
2011
Dasatinib in Imatinib-Resistant Philadelphia Chromosome–Positive Leukemias
2006 Standout
Cancer Epigenetics: From Mechanism to Therapy
2012 Standout
A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma
1996 Standout
Effects of extracellular matrix viscoelasticity on cellular behaviour
2020 StandoutNature
The Epigenomics of Cancer
2007 Standout
Epigenetics in Cancer
2008 Standout
Anticancer activities of histone deacetylase inhibitors
2006 Standout
Histone deacetylase inhibitors as new cancer drugs
2001
Histone-deacetylase inhibitors: novel drugs for the treatment of cancer
2002
Ectopic Expression of Nonliganded Retinoic Acid Receptor β Abrogates AP-1 Activity by Selective Degradation of c-Jun in Cervical Carcinoma Cells
2004 StandoutNobel
Metazoan MicroRNAs
2018 Standout
High Rate of Virologic Suppression with Raltegravir plus Etravirine and Darunavir/Ritonavir among Treatment‐Experienced Patients Infected with Multidrug‐Resistant HIV: Results of the ANRS 139 TRIO Trial
2009
Somatic misexpression of germline P granules and enhanced RNA interference in retinoblastoma pathway mutants
2005 StandoutNatureNobel
Chromatin Modification, Leukaemia and Implications for Therapy
2002
Tumour heterogeneity and cancer cell plasticity
2013 StandoutNature
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
2010 Standout
Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/emtricitabine with lopinavir/ritonavir for initial HIV treatment
2009
miR-10a is aberrantly overexpressed in Nucleophosmin1 mutated acute myeloid leukaemia and its suppression induces cell death
2012
From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites
2016 Standout
Printing ferromagnetic domains for untethered fast-transforming soft materials
2018 StandoutNature
OPTIONS FOR THERAPY IN CHRONIC MYELOID LEUKAEMIA
1995
Apoptosis
2002 Standout
Emerging Biological Principles of Metastasis
2017 Standout
The promise of retinoids to fight against cancer
2001
Physiological and pathological roles for microRNAs in the immune system
2010 Nobel
Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome
2001 Standout
Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia – A Europe Against Cancer Program
2003
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
2013 Standout
Maintenance Treatment with Recombinant Interferon Alfa-2b in Patients with Multiple Myeloma Responding to Conventional Induction Chemotherapy
1990
Pharmacokinetics and Bioavailability of an Integrase and Novel Pharmacoenhancer-Containing Single-Tablet Fixed-Dose Combination Regimen for the Treatment of HIV
2010
Leukaemogenesis: more than mutant genes
2009
Revealing the world of RNA interference
2004 StandoutNatureNobel
Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells
2001 Standout
miR-10a overexpression is associated with NPM1 mutations and MDM4 downregulation in intermediate-risk acute myeloid leukemia
2011
A coding-independent function of gene and pseudogene mRNAs regulates tumour biology
2010 StandoutNature
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Wnt signalling in stem cells and cancer
2005 StandoutNature
Histone deacetylase inhibitors in cancer therapy
2003
Efficacy and safety of ritonavir-boosted dual protease inhibitor therapy in antiretroviral-naive HIV-1-infected patients: the 2IP ANRS 127 study
2009
Chronic Myeloid Leukemia
1999
A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders
2005 Standout
Stem cell-derived polarized hepatocytes
2020 StandoutNobel
Metal–carboxylate interactions in metal–alginate complexes studied with FTIR spectroscopy
2009 Standout
Specific Killing of Ph+Chronic Myeloid Leukemia Cells by a Lentiviral Vector-Delivered Anti-bcr/ablSmall Hairpin RNA
2003
Advances in engineering hydrogels
2017 StandoutScience
Structure of the STRA6 receptor for retinol uptake
2016 StandoutScienceNobel
Molecular Genetics of Adult Acute Myeloid Leukemia: Prognostic and Therapeutic Implications
2011
Acute Myeloid Leukemia
2015 Standout
The miR-29 family: genomics, cell biology, and relevance to renal and cardiovascular injury
2012
Histone deacetylases (HDACs): characterization of the classical HDAC family
2003 Standout
Translocation Products in Acute Myeloid Leukemia Activate the Wnt Signaling Pathway in Hematopoietic Cells
2004
Natural polymers for the microencapsulation of cells
2014
Homoharringtonine therapy induces responses in patients with chronic myelogenous leukemia in late chronic phase
1995
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
2009 Standout
RUNX1 mutations are frequent in de novo AML with noncomplex karyotype and confer an unfavorable prognosis
2010
A feedback circuit involving let-7-family miRNAs and DAF-12 integrates environmental signals and developmental timing in Caenorhabditis elegans
2009 StandoutNobel
Study of Once-Daily Versus Twice-Daily Fosamprenavir plus Ritonavir Administered with Abacavir/Lamivudine Once Daily in Antiretroviral-Naïve HIV-1–Infected Adult Subjects
2009
MicroRNA 29b functions in acute myeloid leukemia
2009
Interferon-Stimulated Genes: A Complex Web of Host Defenses
2014 StandoutNobel
Polymers for 3D Printing and Customized Additive Manufacturing
2017 Standout
Treatment of Philadelphia Chromosome-Positive Early Chronic Phase Chronic Myelogenous Leukemia With Daily Doses of Interferon Alpha and Low-Dose Cytarabine
1999
Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34− fraction
2010
An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: developed for the American Society of Hematology.
1999
A Major Constituent of Brown Algae for Use in High-Capacity Li-Ion Batteries
2011 StandoutScience
The prognostic and functional role of microRNAs in acute myeloid leukemia
2010
Extraction and characterization of an alginate from the brown seaweed Sargassum turbinarioides Grunow
2009
Stress-relaxation behavior in gels with ionic and covalent crosslinks
2010
Multilineage dysplasia has no impact on biologic, clinicopathologic, and prognostic features of AML with mutated nucleophosmin (NPM1)
2010
Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine Kinase
2000 StandoutScience
MLL leukemia induction by genome editing of human CD34+ hematopoietic cells
2015
Does BCR /ABL 1 positive Acute Myeloid Leukaemia Exist?
2013
Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection
2015 Standout
4D Printing with Mechanically Robust, Thermally Actuating Hydrogels
2015
The miR-17-92 microRNA Polycistron Regulates MLL Leukemia Stem Cell Potential by Modulating p21 Expression
2010
Amplification of the MLL gene on double minutes, a homogeneously staining region, and ring chromosomes in five patients with acute myeloid leukemia or myelodysplastic syndrome
2000
The World Health Organization (WHO) classification of the myeloid neoplasms
2002 Standout
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
Robust Distal Tip Cell Pathfinding in the Face of Temperature Stress Is Ensured by Two Conserved microRNAS inCaenorhabditis elegans
2015 StandoutNobel
Chronic Myelogenous Leukemia: Biology and Therapy
1999
Works of Marco Mancini being referenced
Sequential Valproic Acid/All- trans Retinoic Acid Treatment Reprograms Differentiation in Refractory and High-Risk Acute Myeloid Leukemia
2006
Hematological malignancies with a deletion of 11q23: cytogenetic and clinical aspects
1998
NPM1 mutations and cytoplasmic nucleophosmin are mutually exclusive of recurrent genetic abnormalities: a comparative analysis of 2562 patients with acute myeloid leukemia
2008
Clinical outcome and monitoring of minimal residual disease in patients with acute lymphoblastic leukemia expressing the MLL/ENL fusion gene
2011
Epigenetic Silencing of the Myelopoiesis Regulator microRNA-223 by the AML1/ETO Oncoprotein
2007
Once-Daily Atazanavir/Ritonavir Compared With Twice-Daily Lopinavir/Ritonavir, Each in Combination With Tenofovir and Emtricitabine, for Management of Antiretroviral-Naive HIV-1–Infected Patients: 96-Week Efficacy and Safety Results of the CASTLE Study
2010
Rescue of genomic information in adult acute lymphoblastic leukaemia (ALL) with normal/failed cytogenetics: a GIMEMA centralized biological study
2010
Incidence and significance of cryptic chromosome aberrations detected by fluorescence in situ hybridization in acute myeloid leukemia with normal karyotype
2002
A new complex rearrangement involving the ETV6, LOC115548, and MN1 genes in a case of acute myeloid leukemia
2004
Interferon alpha‐2b as therapy for patients with Ph‘‐positive chronic myelogenous leukemia
1990
Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study
2008
Evolving modalities of treatment with interferon alfa-2b for Ph1-positive chronic myelogenous leukaemia
1991
A prospective study of residual-disease monitoring of the ALL1/AF4 transcript in patients with t(4;11) acute lymphoblastic leukemia.
2000
In vitro purging with BCR-ABL antisense oligodeoxynucleotides does not prevent haematologic reconstitution after autologous bone marrow transplantation.
1995
UNIAXIAL COMPRESSION AND STRESS RELAXATION TESTS ON ALGINATE GELS
1999
Rheological behaviour of aqueous dispersions of algal sodium alginates
1996
Polycombs and microRNA-223 regulate human granulopoiesis by transcriptional control of target gene expression
2012
Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin
2008
Interferon alpha-2b as therapy for Ph'-positive chronic myelogenous leukemia: a study of 82 patients treated with intermittent or daily administration
1988
Rheology of alginate from Azotobacter vinelandii in aqueous dispersions
1998
Mechanical properties of alginate gels: empirical characterisation
1999
Histone deacetylase-targeted treatment restores retinoic acid signaling and differentiation in acute myeloid leukemia.
2001
A new morphologic classification system for acute promyelocytic leukemia distinguishes cases with underlying PLZF/RARA gene rearrangements.
2000
Late relapse of acute myeloid leukemia with mutated NPM1 after eight years: evidence of NPM1 mutation stability
2008
BCR-ABL Antisense Oligodeoxynucleotide In Vitro Purging and Autologous Bone Marrow Transplantation for Patients With Chronic Myelogenous Leukemia in Advanced Phase
1998
AML with mutated NPM1 carrying a normal or aberrant karyotype show overlapping biologic, pathologic, immunophenotypic, and prognostic features
2009